Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PAT Implementation Poses Challenge Of Industry-FDA Collaboration

Executive Summary

Collaborating with FDA will be the greatest challenge for industry in implementing the process analytical technology component of FDA's drug quality initiative, AstraZeneca Chemistry, Manufacturing & Controls Group Director Robert Timko said

You may also be interested in...



Novartis Sets Out On The Critical Path; Will Others Follow?

Novartis' announcement of research collaborations with FDA is one of the first tangible outcomes of the agency's Critical Path initiative

Novartis Sets Out On The Critical Path; Will Others Follow?

Novartis' announcement of research collaborations with FDA is one of the first tangible outcomes of the agency's Critical Path initiative

Industry PAT Initiatives Mirror FDA’s Cross-Disciplinary Approach

FDA's effort to create a cross-functional, organization-wide approach to advance process analytical technology from a regulatory vantage point is being mirrored by industry as companies seek to convert PAT theory into practice

UsernamePublicRestriction

Register

PS044841

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel